Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 4/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | USP2 | O75604 | 1/20 | 0.62 |
| ▸ | EGFR | P00533 | 1/20 | 0.62 |
| ▸ | LCK | P06239 | 1/20 | 0.62 |
| ▸ | FYN | P06241 | 1/20 | 0.62 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | HTR2A | P28223 | 1/20 | 0.62 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.62 |
| ▸ | RECQL | P46063 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | PKM | P14618 | 2/20 | 0.56 |
| ▸ | ALPI | P09923 | 1/20 | 0.56 |
| ▸ | XIAP | P98170 | 1/20 | 0.56 |
| ▸ | GRB2 | P62993 | 1/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29481457 | 1.00 | SLC7A5 (0.62) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| SCHEMBL18511382 | 1.00 | SLC7A5 (0.62) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| SCHEMBL44052 | 1.00 | SLC7A5 (0.62) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| SCHEMBL1613644 | 1.00 | SLC7A5 (0.62) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| SCHEMBL29478416 | 1.00 | SLC7A5 (0.62) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| Hydrochloric Acid SCHEMBL23013168 | 0.98 | SLC7A5 (0.60) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| Hydrochloric Acid SCHEMBL29481456 | 0.98 | SLC7A5 (0.60) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| Hydrochloric Acid SCHEMBL28025299 | 0.98 | SLC7A5 (0.60) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| Hydrochloric Acid SCHEMBL23013165 | 0.98 | SLC7A5 (0.60) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| SCHEMBL22557028 | 0.92 | SLC7A5 (0.54) | SLC7A5PTGS1KDM4EUSP2EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1689 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304620-A1 | ANTIMICROBIAL PEPTIDE AND APPLICATION THEREOF | CHINA PHARMACEUTICAL UNIVERSITY (CN) | 2025-10-02 | — | — | US | claimed |
| US-20250130224-A1 | PHOTOREACTIVE ANTIBODY BINDING DOMAINS WITH EPITOPE TAGS FOR MULTIPLEXED ANTIBODY LABELING, DETECTION, AND PURIFICATION | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2025-04-24 | — | — | US | claimed |
| EP-4522221-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACID THERAPEUTICS | Entrada Therapeutics, Inc. (US) | 2025-03-19 | — | — | EP | claimed |
| US-20250073302-A1 | CYCLIC PEPTIDES AS PROTEASOME STIMULATORS | PURDUE RESEARCH FOUNDATION | 2025-03-06 | — | — | US | claimed |
| US-20240368224-A1 | BICYCLIC PEPTIDYL PAN-RAS INHIBITORS | OHIO STATE INNOVATION FOUNDATION | 2024-11-07 | — | — | US | claimed |
| EP-4380620-A2 | PHOTOREACTIVE ANTIBODY BINDING DOMAINS WITH EPITOPE TAGS FOR MULTIPLEXED ANTIBODY LABELING, DETECTION, AND PURIFICATION | The Trustees of The University of Pennsylvania (US) | 2024-06-12 | — | — | EP | claimed |
| EP-4358989-A2 | BICYCLIC PEPTIDYL PAN-RAS INHIBITORS | Ohio State Innovation Foundation (US) | 2024-05-01 | — | — | EP | claimed |
| CN-117915957-A | Compositions and methods for modulating mRNA splicing | 恩特拉达治疗学股份有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-117466974-B | Antimicrobial peptide and application thereof | 中国药科大学 | 2024-03-26 | — | — | CN | claimed |
| EP-4337676-A1 | ANTIGEN-BINDING AND ANTIGEN DEGRADATION CONSTRUCTS | Entrada Therapeutics, Inc. (US) | 2024-03-20 | — | — | EP | claimed |
| WO-2005122379-A2 | ALPHA-4 BETA-1 INTEGRIN LIGANDS FOR IMAGING AND THERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-12-22 | — | — | WO | claimed |
| US-6858577-B1 | Indole peptidomimetics as thrombin receptor antagonists | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2005-02-22 | — | — | US | claimed |
| US-20040063642-A1 | Novel benzimidazolone peptidomimetics as thrombin receptor antagonists | MILLENNIUM PHARMACEUTICALS, INC | 2004-04-01 | — | — | US | claimed |
| US-20030224999-A1 | Novel indole peptidomimetics as thrombin receptor antagonists | ZHANG HAN-CHENG (US) | 2003-12-04 | — | — | US | claimed |
| US-20030199455-A1 | Novel indazole peptidomimetics as thrombin receptor antagonists | MILLENNIUM PHARMACEUTICALS, INC. | 2003-10-23 | — | — | US | claimed |
| US-6630451-B1 | Benzimidazolone peptidometics as thrombin receptor antagonist | ORTHOMCNEIL PHARMACEUTICAL, INC. | 2003-10-07 | — | — | US | claimed |
| WO-2001000656-A2 | NOVEL INDAZOLE PEPTIDOMIMETICS AS THROMBIN RECEPTOR ANTAGONISTS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2001-01-04 | — | — | WO | claimed |
| WO-2001000659-A1 | BENZIMIDAZOLONE PEPTIDOMIMETICS AS THROMBIN RECEPTOR ANTAGONISTS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2001-01-04 | — | — | WO | claimed |
| WO-2001000657-A2 | NOVEL INDOLE PEPTIDOMIMETICS AS THROMBIN RECEPTOR ANTAGONISTS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2001-01-04 | — | — | WO | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250073302-A1 | CYCLIC PEPTIDES AS PROTEASOME STIMULATORS | PSMB11, PSME1, PSMC1 | SLC7A5 4745/4885PTGS1 2657/4885KDM4E 3639/4885 |
| US-20240368224-A1 | BICYCLIC PEPTIDYL PAN-RAS INHIBITORS | KRAS, HRAS, NRAS | SLC7A5 2938/4885PTGS1 3299/4885KDM4E 4608/4885 |
| US-20030224999-A1 | Novel indole peptidomimetics as thrombin receptor antagonists | PTAFR, F2R, F2RL1 | SLC7A5 3680/4885PTGS1 365/4885KDM4E 4377/4885 |
| US-20030199455-A1 | Novel indazole peptidomimetics as thrombin receptor antagonists | PTAFR, F2R, F2RL1 | SLC7A5 4168/4885PTGS1 558/4885KDM4E 4657/4885 |
| US-20040063642-A1 | Novel benzimidazolone peptidomimetics as thrombin receptor antagonists | PTAFR, BDKRB2, BDKRB1 | SLC7A5 4336/4885PTGS1 688/4885KDM4E 4091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.